. | . |
DoD to prioritize overseas personnel in COVID-19 vaccine distribution by Christen Mccurdy Washington DC (UPI) Apr 8, 2021 The Department of Defense is prioritizing distribution of COVID-19 vaccinations to individuals deployed overseas, officials said Thursday. Army Lt. Gen. Ronald J. Place, director of the Defense Health Agency, told reporters Thursday that deployed personnel are being prioritized due to limited availability of vaccinations from local health providers, according to a Pentagon press release. The DoD has set aside 14% of the vaccine doses it has received for overseas personnel, Place said, noting that they make up 7% of the DoD's eligible population. "That said if you're a service member stationed overseas, or a family member likewise stationed overseas and you haven't received a vaccine, and you don't know when you'll be able to, these numbers mean nothing. And it's understandably frustrating," Place said. Place said the military isn't vaccinating personnel as quickly as officials would like due to the loss of 15 million doses of the Johnson & Johnson due to contamination last week. According to Place, the number of military personnel outside the continental U.S. is" 10 or 15 percent higher rates than the continental United States at this point." Place also said that the Department of Defense has administered about 688,000 vaccines to personnel as of Wednesday. "Now, some of those are -- are first dose and second dose but fully vaccinated of -- people with second dose, of the vaccine given, we have about 67 percent of those individuals," Place said. Adm. Gayle Shaffer, deputy surgeon general of the Navy, said roughly 35% of active-duty Navy personnel have been vaccinated. According to Air Force Maj. Gen. Robert I. Miller, director of medical operations, office of the surgeon general, U.S. Air Force, 11.1% of Air Force personnel have received at least one dose of a vaccine and 7.2% have received two shots. In the general U.S. population, as of Thursday, 33.7% have had at least one dose of the COVID-19 vaccine and 19.9% are fully vaccinated, according to data from the Centers for Disease Control and Prevention. At the end of March Acting Assistant Secretary of Defense for Health Affairs Dr. Terry Adirim said it's possible that by early summer, every person in the DoD could be vaccinated. On Thursday Place said all DoD installations will be opening vaccination eligibility to all tiers of the population, consistent with President Joe Biden's announcement of changed eligibility requirements earlier this week. At the end of March Rep. Jimmy Panetta, D-Calif., sent a letter to the White House Wednesday along with six other House Democrats, urging Biden to issue a waiver making the COVID-19 vaccine mandatory for service members. On Thursday Place said all individuals will have an opportunity to be vaccinated before deployment, but the vaccine is "not a mandatory requirement for readiness." As of Thursday the Department of Defense had reported a cumulative total of 271,470 cases since the COVID-19 pandemic began -- up from 262,395 March 25. Of those, 177,359 were among active-duty military, 49,430 among civilian DoD employees, 26,905 among dependents and 17,776 among DoD contractors. Most -- 256,264 -- have recovered, but 3,814 were hospitalized and 332 have died.
Hong Kong suspends its order of AstraZeneca jabs Europe's medicines regulator said this week the AstraZeneca vaccine could cause very rare blood clots in some recipients, prompting a cascade of countries to pull the plug on giving it to people under a certain age. Britain sought Thursday to quell fears over the jab, saying the potential side effects were extremely rare -- and the risk of falling seriously sick from Covid-19 was far greater. On Friday Hong Kong's health chief Sophia Chan said the city has asked AstraZeneca not to deliver as planned later this year. "We think it is not necessary for AstraZeneca to deliver the vaccines to the city within this year," she said, adding Hong Kong wanted "to avoid any waste as vaccines are in short supply globally". Wealthy Hong Kong has already secured a good supply of vaccines for its 7.5 million residents. It has signed deals for 7.5 million shots each with BioNTech/Pfizer and China's Sinovac, both of which have begun deliveries. Chan said Hong Kong was also keen to look at other vaccines that may have stronger results against newer strains of the coronavirus. Earlier this week David Hui, a leading public health expert and government adviser, called for Hong Kong to replace AstraZeneca with a new single dose vaccine made by Johnson and Johnson. Densely populated Hong Kong was one of the first places to be hit by the coronavirus, but strict social distancing and universal mask wearing have helped keep infections to just over 11,000 with 205 deaths. While it has a steady supply of vaccines, take up has been slow amid swirling distrust of the government as Beijing cracks down on democracy supporters. So far just 529,000 people have had their first dose. Public confidence has also been hampered by government messaging. China's Sinovac received fast-track approval despite not publishing its clinical trial data in a peer reviewed journal. Administration of BioNTech's vaccine was also briefly suspended after some vials were found to be defective even though authorities said any damaged bottles were discarded before being used in vaccinations.
China weighs carrots and sticks in push to vaccinate millions Beijing (AFP) April 8, 2021 Tickets to tourist attractions, shopping coupons, and report cards naming and shaming stores where staff haven't been vaccinated: China is veering from compulsion to persuasion in its bid to inoculate its population from Covid. The country has administered around 140 million doses - most people will require two shots - since vaccinations began last year and aims to fully inoculate 40 percent of its 1.4 billion people by June. But many in China have been slow to sign up for jabs, feeling they a ... read more
|
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |